Allarity Therapeutics, Inc.
ALLR
$1.52
-$0.16-9.52%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -3.37M | -2.81M | -2.32M | -2.73M | -7.45M |
| Total Depreciation and Amortization | 8.00K | -44.00K | 12.00K | 11.00K | 1.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.42M | 256.00K | 247.00K | 184.00K | -106.00K |
| Change in Net Operating Assets | -1.30M | -816.00K | -3.42M | -149.00K | 4.35M |
| Cash from Operations | -3.24M | -3.41M | -5.48M | -2.69M | -3.21M |
| Capital Expenditure | -8.00K | -- | -- | -- | -298.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -8.00K | -- | -- | -- | -298.00K |
| Total Debt Issued | -- | -- | -- | -- | 0.00 |
| Total Debt Repaid | -- | -- | -- | -- | 0.00 |
| Issuance of Common Stock | 244.00K | 2.45M | 0.00 | 11.14M | 4.24M |
| Repurchase of Common Stock | -484.00K | -141.00K | -2.57M | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | 0.00 |
| Repurchase of Preferred Stock | -- | -- | -- | -- | 0.00 |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -240.00K | 2.31M | -2.57M | 11.14M | 4.24M |
| Foreign Exchange rate Adjustments | 1.28M | 194.00K | -1.86M | -286.00K | 339.00K |
| Miscellaneous Cash Flow Adjustments | 1.00K | -- | -- | -- | -- |
| Net Change in Cash | -2.21M | -906.00K | -9.90M | 8.17M | 1.07M |